ArticleMolecular oncology2024

NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study.

Satoshi Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.